101 related articles for article (PubMed ID: 22868228)
41. Ultraviolet light and photosensitising agents activate TRPA1 via generation of oxidative stress.
Hill K; Schaefer M
Cell Calcium; 2009 Feb; 45(2):155-64. PubMed ID: 18814910
[TBL] [Abstract][Full Text] [Related]
42. Identification and functional characterization of TRPA1 in human myoblasts.
Osterloh M; Böhm M; Kalbe B; Osterloh S; Hatt H
Pflugers Arch; 2016 Feb; 468(2):321-33. PubMed ID: 26328519
[TBL] [Abstract][Full Text] [Related]
43. Transient receptor potential ankyrin 1 (TRPA1) antagonists.
Preti D; Saponaro G; Szallasi A
Pharm Pat Anal; 2015; 4(2):75-94. PubMed ID: 25853468
[TBL] [Abstract][Full Text] [Related]
44. Transnitrosylation directs TRPA1 selectivity in N-nitrosamine activators.
Kozai D; Kabasawa Y; Ebert M; Kiyonaka S; ; Otani Y; Numata T; Takahashi N; Mori Y; Ohwada T
Mol Pharmacol; 2014 Jan; 85(1):175-85. PubMed ID: 24202912
[TBL] [Abstract][Full Text] [Related]
45. Identification of molecular determinants for a potent mammalian TRPA1 antagonist by utilizing species differences.
Nakatsuka K; Gupta R; Saito S; Banzawa N; Takahashi K; Tominaga M; Ohta T
J Mol Neurosci; 2013 Nov; 51(3):754-62. PubMed ID: 23872983
[TBL] [Abstract][Full Text] [Related]
46. Activation of TRPA1 by luminal stimuli induces EP4-mediated anion secretion in human and rat colon.
Kaji I; Yasuoka Y; Karaki S; Kuwahara A
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(7):G690-701. PubMed ID: 22207576
[TBL] [Abstract][Full Text] [Related]
47. Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel.
Ryckmans T; Aubdool AA; Bodkin JV; Cox P; Brain SD; Dupont T; Fairman E; Hashizume Y; Ishii N; Kato T; Kitching L; Newman J; Omoto K; Rawson D; Strover J
Bioorg Med Chem Lett; 2011 Aug; 21(16):4857-9. PubMed ID: 21741838
[TBL] [Abstract][Full Text] [Related]
48. Transient receptor potential ankyrin 1: emerging pharmacology and indications for cardiovascular biology.
Bodkin JV; Brain SD
Acta Physiol (Oxf); 2011 Sep; 203(1):87-98. PubMed ID: 20950342
[TBL] [Abstract][Full Text] [Related]
49. TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD.
Stokes A; Wakano C; Koblan-Huberson M; Adra CN; Fleig A; Turner H
Cell Signal; 2006 Oct; 18(10):1584-94. PubMed ID: 16500080
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists.
Johnson SG; Gunnet JW; Moore JB; Miller W; Wines P; Rivero RA; Combs D; Demarest KT
Bioorg Med Chem Lett; 2006 Jul; 16(13):3362-6. PubMed ID: 16650762
[TBL] [Abstract][Full Text] [Related]
51. Rb+ efflux assay for assessment of non-selective cation channel activities.
Liu K; Samuel M; Harrison RK; Paslay JW
Assay Drug Dev Technol; 2010 Jun; 8(3):380-8. PubMed ID: 20085483
[TBL] [Abstract][Full Text] [Related]
52. Biaryl tetrazolyl ureas as inhibitors of endocannabinoid metabolism: modulation at the N-portion and distal phenyl ring.
Ortar G; Morera E; De Petrocellis L; Ligresti A; Schiano Moriello A; Morera L; Nalli M; Ragno R; Pirolli A; Di Marzo V
Eur J Med Chem; 2013 May; 63():118-32. PubMed ID: 23474898
[TBL] [Abstract][Full Text] [Related]
53. Thymol and related alkyl phenols activate the hTRPA1 channel.
Lee SP; Buber MT; Yang Q; Cerne R; Cortés RY; Sprous DG; Bryant RW
Br J Pharmacol; 2008 Apr; 153(8):1739-49. PubMed ID: 18334983
[TBL] [Abstract][Full Text] [Related]
54. Some like it pungent and vile. TRPA1 as a molecular target for the malodorous vinyl disulfides from asafoetida.
Shokoohinia Y; Chianese G; Appendino G; Di Marzo V; De Petrocellis L; Ghannadi A; Taghvayi R; Fattahian K; Soltani R; Taglialatela-Scafati O
Fitoterapia; 2013 Oct; 90():247-51. PubMed ID: 23954176
[TBL] [Abstract][Full Text] [Related]
55. N-isoquinolin-5-yl-N'-aralkyl-urea and -amide antagonists of human vanilloid receptor 1.
Jetter MC; Youngman MA; McNally JJ; Zhang SP; Dubin AE; Nasser N; Dax SL
Bioorg Med Chem Lett; 2004 Jun; 14(12):3053-6. PubMed ID: 15149643
[TBL] [Abstract][Full Text] [Related]
56. Carbazole-containing amides and ureas: Discovery of cryptochrome modulators as antihyperglycemic agents.
Humphries PS; Bersot R; Kincaid J; Mabery E; McCluskie K; Park T; Renner T; Riegler E; Steinfeld T; Turtle ED; Wei ZL; Willis E
Bioorg Med Chem Lett; 2018 Feb; 28(3):293-297. PubMed ID: 29292223
[TBL] [Abstract][Full Text] [Related]
57. Boosting that tan with a bit of voltage.
Caterina MJ
Channels (Austin); 2013; 7(6):417. PubMed ID: 24088950
[No Abstract] [Full Text] [Related]
58. 1-(N-acylamino)alkyl sulfones from N-acyl-α-amino acids or N-alkylamides.
Adamek J; Mazurkiewicz R; Październiok-Holewa A; Grymel M; Kuźnik A; Zielińska K
J Org Chem; 2014 Mar; 79(6):2765-70. PubMed ID: 24575944
[TBL] [Abstract][Full Text] [Related]
59. Copper-mediated N-alkynylation of carbamates, ureas, and sulfonamides. A general method for the synthesis of ynamides.
Dunetz JR; Danheiser RL
Org Lett; 2003 Oct; 5(21):4011-4. PubMed ID: 14535766
[TBL] [Abstract][Full Text] [Related]
60. Straightforward access to N-trifluoromethyl amides, carbamates, thiocarbamates and ureas.
Scattolin T; Bouayad-Gervais S; Schoenebeck F
Nature; 2019 Sep; 573(7772):102-107. PubMed ID: 31485055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
